290 related articles for article (PubMed ID: 31897807)
1. Application and Impact of Human Dose Projection from Discovery to Early Drug Development.
Patel D; Yang W; Lipert M; Wu T
AAPS PharmSciTech; 2020 Jan; 21(2):44. PubMed ID: 31897807
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics/pharmacodynamics model-supported early drug development.
Chen B; Dong JQ; Pan WJ; Ruiz A
Curr Pharm Biotechnol; 2012 Jun; 13(7):1360-75. PubMed ID: 22201585
[TBL] [Abstract][Full Text] [Related]
3. An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles.
Kalaria DR; Parker K; Reynolds GK; Laru J
Drug Discov Today; 2020 Mar; 25(3):505-518. PubMed ID: 31926318
[TBL] [Abstract][Full Text] [Related]
4. Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery.
Lucas AJ; Sproston JL; Barton P; Riley RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1313-1327. PubMed ID: 31538500
[No Abstract] [Full Text] [Related]
5. An overview of late-stage functionalization in today's drug discovery.
Moir M; Danon JJ; Reekie TA; Kassiou M
Expert Opin Drug Discov; 2019 Nov; 14(11):1137-1149. PubMed ID: 31411499
[No Abstract] [Full Text] [Related]
6. The problem of racemization in drug discovery and tools to predict it.
Ballard A; Narduolo S; Ahmad HO; Cosgrove DA; Leach AG; Buurma NJ
Expert Opin Drug Discov; 2019 Jun; 14(6):527-539. PubMed ID: 30882254
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on the Role of Mathematics in Drug Discovery and Development.
Allen R; Moore H
Bull Math Biol; 2019 Sep; 81(9):3425-3435. PubMed ID: 30693431
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic applications of click chemistry for pharmaceutical drug discovery and drug delivery.
Meghani NM; Amin HH; Lee BJ
Drug Discov Today; 2017 Nov; 22(11):1604-1619. PubMed ID: 28754291
[TBL] [Abstract][Full Text] [Related]
9. Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.
Chen Y; Jin JY; Mukadam S; Malhi V; Kenny JR
Biopharm Drug Dispos; 2012 Mar; 33(2):85-98. PubMed ID: 22228214
[TBL] [Abstract][Full Text] [Related]
10. Model-based Target Pharmacology Assessment (mTPA): An Approach Using PBPK/PD Modeling and Machine Learning to Design Medicinal Chemistry and DMPK Strategies in Early Drug Discovery.
Chen EP; Bondi RW; Michalski PJ
J Med Chem; 2021 Mar; 64(6):3185-3196. PubMed ID: 33719432
[TBL] [Abstract][Full Text] [Related]
11. Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review.
Loisios-Konstantinidis I; Paraiso RLM; Fotaki N; McAllister M; Cristofoletti R; Dressman J
J Pharm Pharmacol; 2019 Apr; 71(4):699-723. PubMed ID: 30793317
[TBL] [Abstract][Full Text] [Related]
12. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
[TBL] [Abstract][Full Text] [Related]
13. Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules.
Bassani D; Parrott NJ; Manevski N; Zhang JD
Expert Opin Drug Discov; 2024 Jun; 19(6):683-698. PubMed ID: 38727016
[TBL] [Abstract][Full Text] [Related]
14. Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective.
Wong H; Bohnert T; Damian-Iordache V; Gibson C; Hsu CP; Krishnatry AS; Liederer BM; Lin J; Lu Q; Mettetal JT; Mudra DR; Nijsen MJMA; Schroeder P; Schuck E; Suryawanshi S; Trapa P; Tsai A; Wang H; Wu F
Drug Discov Today; 2017 Oct; 22(10):1447-1459. PubMed ID: 28476536
[TBL] [Abstract][Full Text] [Related]
15. In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development.
Zane P; Gieschen H; Kersten E; Mathias N; Ollier C; Johansson P; Van den Bergh A; Van Hemelryck S; Reichel A; Rotgeri A; Schäfer K; Müllertz A; Langguth P
Eur J Pharm Biopharm; 2019 Sep; 142():222-231. PubMed ID: 31233862
[TBL] [Abstract][Full Text] [Related]
16. Dose Predictions for Drug Design.
Maurer TS; Smith D; Beaumont K; Di L
J Med Chem; 2020 Jun; 63(12):6423-6435. PubMed ID: 31913040
[TBL] [Abstract][Full Text] [Related]
17. Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development.
Yang W; Bhattachar SN; Patel PJ; Landis M; Patel D; Reid DL; Duvnjak Romic M
Drug Discov Today; 2021 Mar; 26(3):713-723. PubMed ID: 33333320
[TBL] [Abstract][Full Text] [Related]
18. Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry.
Stone JA; Banfield C; Pfister M; Tannenbaum S; Allerheiligen S; Wetherington JD; Krishna R; Grasela DM
J Clin Pharmacol; 2010 Sep; 50(9 Suppl):20S-30S. PubMed ID: 20881214
[TBL] [Abstract][Full Text] [Related]
19. Application of PBPK modelling in drug discovery and development at Pfizer.
Jones HM; Dickins M; Youdim K; Gosset JR; Attkins NJ; Hay TL; Gurrell IK; Logan YR; Bungay PJ; Jones BC; Gardner IB
Xenobiotica; 2012 Jan; 42(1):94-106. PubMed ID: 22035569
[TBL] [Abstract][Full Text] [Related]
20. R and nlmixr as a gateway between statistics and pharmacometrics.
Fidler M; Hooijmaijers R; Schoemaker R; Wilkins JJ; Xiong Y; Wang W
CPT Pharmacometrics Syst Pharmacol; 2021 Apr; 10(4):283-285. PubMed ID: 33951757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
